Formulations of bendamustine | Patent Number 10052385

US 10052385 B2
Application Number15432378
Publication NumberUS 20180000938 A1
Pendency1 year, 6 months, 8 days
Filled DateFeb 14, 2017
Priority DateMar 20, 2012
Publication DateJan 4, 2018
Expiration DateMar 19, 2032
Inventor/ApplicantsSrikanth Sundaram
ExaminesIVANOVA, SVETLANA M
Art Unit1627
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.